House Appropriations committee reports bill to create Vermont Rare Disease Advisory Council

The House Appropriations Committee on May 8 reported H.46 favorably to create a Rare Disease Advisory Council within the Vermont Department of Health, after members heard bill language from Legislative Council and a fiscal summary from the Legislature's fiscal staff.

Katie McGlynn, Legislative Counsel with the Office of Legislative Council, told the committee the bill "creates a Rare Disease Advisory Council within the Department of Health to provide guidance and recommendations to the public, General Assembly, and other governmental agencies and departments as necessary regarding the needs of individuals living with rare diseases in Vermont." The bill lays out membership categories, duties and meeting requirements, McGlynn said.

The council would include two individuals living with a rare disease (at least one an older Vermonter), a parent or guardian of a person with a rare disease, the Commissioner of Health or a designee, the Commissioner of [agency name unclear in the transcript] or designee, a representative of the Health Equity Advisory Commission, an academic researcher who conducts rare disease research, a physician and nurse with experience treating rare disease, a pharmacist and a geneticist or genetic counselor, with appointments made by specified legislative leaders and professional organizations.

Fiscal staff summarized the bill's financial implications, saying the anticipated impact to the Department of Health would be "nominal" and could be absorbed within existing budgets. Fiscal office staff estimated annual costs for convening meetings, maintaining a webpage and modest per-diem or expense reimbursements would be well below $10,000 and likely under $5,000; they advised no separate appropriation appeared necessary. The transcript records the fiscal conclusion as: "the impact to VDH would be nominal, and can be captured within their budget."

Under the bill text reviewed by the committee, the advisory council would convene public hearings, solicit comments from affected individuals, assist with a needs assessment identifying gaps in services for people with rare diseases and their caregivers, provide testimony on pending legislation and consult with experts to support newborn screening recommendations and timely access to diagnostics and treatment. The council would maintain a webpage on the Department of Health site with meeting notices, minutes and public comments, meet quarterly, and members not otherwise compensated would be eligible for expenses for not more than four meetings annually.

Committee members asked clarifying questions about definitions and prevalence of rare diseases. One committee member noted a national definition cited in public resources that counts rare diseases as those affecting fewer than 200,000 people in the United States, and members discussed that some rare diseases may not have specific drug treatments. McGlynn and fiscal staff emphasized the bill is focused on creating the council and does not itself appropriate funding for new treatments.

A motion to report H.46 favorably was made and the committee recorded a roll-call approval. The transcript records the chair calling the roll and ending with a tally given as "9 0 2," and the committee designated the Department of Health as the reporter of the bill.

Committee members also noted a quirk in the draft's effective date language, which reads "07/01/1926" in the bill text; the committee flagged that as a drafting error during the discussion. The bill is an H. bill and will proceed through the legislative process as reported by the committee.